flâneur

APOE2 is associated with longevity independent of Alzheimer’s disease - PMC

ncbi.nlm.nih.gov · 8,829 words · saved by 1 readers

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now. 1Department of Neuroscience, Mayo Clinic, Jacksonville, United States 2Department of Aging Neurobiology, National Center for Geriatrics and Gerontology, Aichi, Japan 1Department of Neuroscience, Mayo Clinic, Jacksonville, United States 3Neuroscience Graduate Program, Mayo Clinic, Jacksonville, United States 1Department of Neuroscience, Mayo Clinic, Jacksonville, United States 4United Graduate School of Child Development, Osaka University, Osaka, Japan 1Dep

Abstract Although the ε2 allele of apolipoprotein E (APOE2) benefits longevity, its mechanism is not understood. The protective effects of the APOE2 on Alzheimer’s disease (AD) risk, particularly through their effects on amyloid or tau accumulation, may confound APOE2 effects on longevity. Herein, we showed that the association between APOE2 and longer lifespan persisted irrespective of AD status, including its neuropathology, by analyzing clinical datasets as well as animal models. Notably, APOE2 was associated with preserved activity during aging, which also associated with lifespan. In…

saved by

related reading